Enveloped viruses use specialized fusion proteins to enter their host cells. Merger of the viral envelope with cellular membrane leads to delivery of viral nucleocapsid into the cytosol and initiates infection. Hemagglutinin (HA) of influenza virus and gp160 of HIV are the most abundant proteins of the viral envelope. The high mutation rates of HA and gp160 complicate development of universal vaccines against these viruses. However, as proteins change their conformation during fusion, they transiently expose cryptic, highly conserved sites to neutralizing antibodies and drugs. Therefore, studies of the molecular mechanisms of the molecular mechanisms of fusion and the changes in fusion proteins are not only important from the point of view of fundamental science, but also for designing new strategies to fight viral infection. The core structures of a number of viral fusion proteins share a striking similarity: they all fold into a so-called hairpin motif. However, the relevance fo this structure to fusion is not known. The hypothesis that folding of fusion proteins into a hairpin structure leads to fusion pore formation will be tested. Cells expressing HA and gp160 will be bound and fused to target cells carrying appropriate receptors. Fluorescence microscopy and real-time electrical admittance measurements will be used to monitor the extent and the kinetics of fusion induced by these proteins. The fusion reaction will be arrested at an intermediate stage upstream of fusion pore by sub-optimal temperatures. The conformational states of HA and gp160 will be explored along with concomitant lipid rearrangements induced by these proteins. The stages at which the proteins acquired the final hairpin structure will be explored with inhibitory peptides that bind to intermediate conformations of fusion proteins and prevent hairpin formation. Amphipathic agents that selectively destabilize and convert the local merger of outer leaflets of membranes into full fusion will be used to determine whether hemifusion has occurred at the intermediate stage. This interdisciplinary approach will be used to determine the rate-limiting stages of fusion for both HA and gp160 by dissecting the temperature- dependence of early and late stages of fusion.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM054787-06
Application #
6386631
Study Section
Biophysical Chemistry Study Section (BBCB)
Program Officer
Shapiro, Bert I
Project Start
1996-08-01
Project End
2004-07-31
Budget Start
2001-08-01
Budget End
2002-07-31
Support Year
6
Fiscal Year
2001
Total Cost
$240,240
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Xu, Jimmy P; Francis, Ashwanth C; Meuser, Megan E et al. (2018) Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action. J Drug Des Res 5:
Dragovic, Srdjan M; Agunbiade, Tolulope A; Freudzon, Marianna et al. (2018) Immunization with AgTRIO, a Protein in Anopheles Saliva, Contributes to Protection against Plasmodium Infection in Mice. Cell Host Microbe 23:523-535.e5
Francis, Ashwanth C; Melikyan, Gregory B (2018) Single HIV-1 Imaging Reveals Progression of Infection through CA-Dependent Steps of Docking at the Nuclear Pore, Uncoating, and Nuclear Transport. Cell Host Microbe 23:536-548.e6
Francis, Ashwanth C; Melikyan, Gregory B (2018) Live-Cell Imaging of Early Steps of Single HIV-1 Infection. Viruses 10:
Zaitseva, Elena; Zaitsev, Eugene; Melikov, Kamran et al. (2017) Fusion Stage of HIV-1 Entry Depends on Virus-Induced Cell Surface Exposure of Phosphatidylserine. Cell Host Microbe 22:99-110.e7
Hammonds, Jason E; Beeman, Neal; Ding, Lingmei et al. (2017) Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1. PLoS Pathog 13:e1006181
Sood, Chetan; Francis, Ashwanth C; Desai, Tanay M et al. (2017) An improved labeling strategy enables automated detection of single-virus fusion and assessment of HIV-1 protease activity in single virions. J Biol Chem 292:20196-20207
Melikyan, Gregory B (2017) How entry inhibitors synergize to fight HIV. J Biol Chem 292:16511-16512
Sood, Chetan; Marin, Mariana; Chande, Ajit et al. (2017) SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins. J Biol Chem 292:6014-6026
Hampton, Cheri M; Strauss, Joshua D; Ke, Zunlong et al. (2017) Correlated fluorescence microscopy and cryo-electron tomography of virus-infected or transfected mammalian cells. Nat Protoc 12:150-167

Showing the most recent 10 out of 29 publications